Page last updated: 2024-11-07

spironolactone and Angor Pectoris

spironolactone has been researched along with Angor Pectoris in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Peuter, OR1
Lip, GY1
Souverein, PC1
Klungel, OH1
de Boer, A1
Büller, HR1
Kamphuisen, PW1
Schröder, R1
Schüren, KP1
Biamino, G1
Meyer, V1
Sadée, W1

Other Studies

2 other studies available for spironolactone and Angor Pectoris

ArticleYear
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
    European journal of heart failure, 2011, Volume: 13, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin-Converting Enzyme

2011
[Positive-inotropic heart effect of aldadiene-potassium (Aldactone pro injections)].
    Klinische Wochenschrift, 1971, Oct-01, Volume: 49, Issue:19

    Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Central Venous Pressure; H

1971